MarketStudyReport.com adds “Global Topiramate (CAS 97240-79-4) Market Outlook 2016-2021” new report to its research database. The report spread across 100 pages with table and figures in it.
Topiramate (brand name Topamax) is an anticonvulsant (antiepilepsy) drug. In late 2012, topiramate was approved by the United States Food and Drug Administration (FDA) in combination with phentermine for weight loss. The drug had previously been used off-label for this purpose. Topiramate was originally produced by Ortho-McNeil Neurologics and Noramco, Inc., both divisions of the Johnson & Johnson Corporation. This medication was discovered in 1979 by Bruce E. Maryanoff and Joseph F. Gardocki during their research work at McNeil Pharmaceutical.
Browse full table of contents and data tables at https://www.marketstudyreport.com/reports/global-topiramate-cas-97240-79-4-market-outlook-2016-2021/
This report provides detailed analysis of worldwide markets for Topiramate (CAS 97240-79-4) from 2011-2015 and provides extensive market forecasts 2016-2021 by region/country and subsectors. It covers the key technological and market trends in the Topiramate (CAS 97240-79-4) market and further lays out an analysis of the factors influencing the supply/demand for Topiramate (CAS 97240-79-4), and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies.
The report, Global Topiramate (CAS 97240-79-4) Market Outlook 2016-2021, has been prepared based on the synthesis, analysis, and interpretation of information about the global Topiramate (CAS 97240-79-4) market collected from specialized sources. The report covers key technological developments in the recent times and profiles leading players in the market and analyzes their key strategies. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The major players in the global Topiramate (CAS 97240-79-4) market are Unimark Remedies (India), Janssen Pharmaceutica (Belgium), Taj Pharmaceuticals (India), ScinoPharm (Taiwan), among others.
The report provides separate comprehensive analytics for the North America, Europe, Asia-Pacific, Middle East and Africa and Rest of World. In this sector, global competitive landscape and supply/demand pattern of Topiramate (CAS 97240-79-4) industry has been provided.
To receive personalized assistance, write to us @ firstname.lastname@example.org with the report title in the subject line along with your questions or call us at +1 866-764-2150